AxonDAO has selected Oracle Cloud Infrastructure to build and scale secure GPU capacity for AI and life sciences workloads.
Why this matters for research workloads
Life sciences work carries data handling requirements that general compute does not. Where data physically sits, who can reach it, and what is logged are not details to settle after the fact — they determine whether a dataset can be used at all.
Moving to enterprise-grade infrastructure gives those questions concrete answers during intake rather than case-by-case afterwards.
What changes for existing users
Nothing immediately. Existing workloads continue as they are. The capacity added through this partnership is additional rather than a migration.
What to expect next
Enterprise intake now covers data residency requirements explicitly. If you have constraints on where data may be processed, raise them at intake — it is much cheaper to design around them than to discover them mid-engagement.